A Human Controlled Infection Study with Neisseria Lactamica in Malian Adults

NACompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

March 2, 2021

Primary Completion Date

October 10, 2021

Study Completion Date

June 6, 2023

Conditions
Meningitis, Meningococcal
Interventions
BIOLOGICAL

Intranasal inoculation with Neisseria lactamica

Lyophilised Neisseria lactamica will be reconstituted and administered to participants intranasally.

Trial Locations (1)

Unknown

CVD Mali, Bamako

All Listed Sponsors
collaborator

University of Southampton

OTHER

collaborator

University of Maryland

OTHER

collaborator

University College, London

OTHER

collaborator

University of Oxford

OTHER

collaborator

Public Health England

OTHER_GOV

lead

Center for Vaccine Development - Mali

OTHER

NCT04665791 - A Human Controlled Infection Study with Neisseria Lactamica in Malian Adults | Biotech Hunter | Biotech Hunter